Take the First Step to Relief: Ulcerative Colitis Treatment in Glen Burnie MD

At the Nasseri Clinic of Arthritic and Rheumatic Diseases, recommendations for injectable therapies are based on a comprehensive evaluation of each patient’s disease severity, treatment history, and individual health factors. Injectable therapies—including biologic medications, and other targeted treatments—are typically considered for patients with moderate to severe rheumatic or arthritic conditions (such as rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis) who have not responded adequately to conventional treatments like NSAIDs, disease-modifying antirheumatic drugs (DMARDs), or corticosteroids.
 
Our clinic also assesses whether patients have experienced significant side effects or intolerance to oral medications. Diagnostic tools such as laboratory tests, imaging studies, and detailed symptom assessments are used to determine disease activity and the need for advancing to injectable therapies.

Patients with contraindications to standard therapies, those at increased risk for disease complications, or those requiring rapid disease control may be prioritized for injectable biologics. Every decision at the Nasseri Clinic is individualized, ensuring a careful balance between the benefits and potential risks of injectable therapy for each patient’s unique situation.
 
Continuous monitoring and regular follow-up are essential components of our treatment approach once injectable therapy is initiated, allowing us to assess effectiveness, manage side effects, and adjust treatment as needed to achieve the best possible outcomes for our patients.

At Nasseri Clinic of Arthritic and Rheumatic Diseases, we provide comprehensive care for patients with ulcerative colitis, recognizing the close relationship between inflammatory bowel disease and autoimmune or rheumatic conditions. Our multidisciplinary team closely monitors the effectiveness of treatment through a combination of clinical assessment, laboratory testing, and when needed, advanced imaging or endoscopic procedures.
 
During follow-up visits, our providers evaluate your symptoms—such as stool frequency, the presence of blood, abdominal pain, joint discomfort, and overall well-being. Tracking these symptoms is vital, as changes often give the first indication of your response to therapy.
 
In addition to symptom monitoring, we routinely order laboratory tests to assess inflammation markers like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). These same tests are frequently used in the management of rheumatic diseases, allowing us to take a holistic approach to your care. We also monitor for anemia or other complications. Stool tests, such as fecal calprotectin, may be used to detect ongoing inflammation in the colon—even if symptoms are mild or absent.
 
If symptoms persist or if lab results suggest active disease, our clinic may recommend further evaluation with imaging studies, such as abdominal ultrasound or magnetic resonance enterography (MRE). When necessary, colonoscopy or flexible sigmoidoscopy can provide direct visualization of the colon and allow for targeted tissue sampling. These procedures help us gauge the extent of disease activity and make informed adjustments to your treatment plan.
 
Throughout this process, our care team carefully reviews any side effects or concerns you may have about your medications, with a strong focus on safety and patient education. Our goal is to provide coordinated, patient-centered care that not only manages your ulcerative colitis but also addresses any overlapping rheumatic or autoimmune concerns—helping you achieve the best possible quality of life.

At the Nasseri Clinic of Arthritic and Rheumatic Diseases, we take a comprehensive approach to monitoring the effectiveness of treatment for patients with ulcerative colitis, particularly when it occurs alongside rheumatic or inflammatory conditions. Our clinic utilizes a combination of advanced laboratory tests to closely assess inflammation, anemia, and overall patient well-being.

A key component of our monitoring protocol is the complete blood count (CBC), which helps us detect anemia—a frequent complication in both ulcerative colitis and certain rheumatic diseases—and to identify elevated white blood cell counts that can signal ongoing inflammation or infection. In addition to the CBC, we routinely evaluate inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). These markers are valuable for tracking the degree of systemic inflammation, which is important in both gastrointestinal and rheumatic disease management.
 
For a more direct assessment of intestinal inflammation, we may recommend a fecal calprotectin test. This noninvasive stool test is highly sensitive in detecting active inflammation in the colon and is an important tool for distinguishing between gastrointestinal and extraintestinal disease activity, which is especially relevant in patients with coexisting rheumatic diseases.
 
Given that many medications used to treat both ulcerative colitis and rheumatic diseases can impact organ function, our clinic also regularly monitors liver and kidney function. For patients on immunosuppressive therapies such as thiopurines, we may check thiopurine metabolite levels to ensure optimal drug efficacy while minimizing the risk of toxicity.

If you are navigating the challenges of Ulcerative Colitis (UC) in the Glen Burnie area, the Nasseri Clinic of Arthritic and Rheumatic Diseases provides highly specialized and comprehensive care. Under the direction of Dr. Nasser Nasseri, MD, the clinic focuses on collaborative, tailored treatment to bring about long-term disease remission.

Dr. Nasseri’s Personalized Approach

Dr. Nasseri and his experienced team view Ulcerative Colitis not just as a gastrointestinal condition, but as a complex autoimmune disorder. Their commitment is to a collaborative model of care that places the patient at the center.

They aim to provide personalized strategies that go beyond symptoms:

• Integrated Care: Recognizing the strong link between UC and conditions like inflammatory arthritis, the clinic is uniquely equipped to manage both your gastrointestinal inflammation and any joint pain or systemic complications that may arise.

• Open Communication: We prioritize open discussion regarding treatment options, potential side effects, and benefits, ensuring you are an empowered partner in managing your chronic condition.

• Holistic Focus: Management extends to monitoring for complications like bone loss and addressing the emotional well-being (such as anxiety or depression) that often accompanies living with a chronic disease.

Nasseri Clinic of Arthritic and Rheumatic Diseases is dedicated to providing personalized, evidence-based care for patients with ulcerative colitis, especially those with overlapping rheumatic conditions. For more information, contact us or schedule an appointment online. We are conveniently located at 203 Hospital Dr, Suite 300B, Glen Burnie, MD 21061. We serve patients from Glen Burnie MD, Pasadena MD, Jacobsville MD, Ferndale MD, Severn MD, and surrounding areas.